RxDoctor Payments Data

Zachary Fisk, MD

Pain Medicine · Bellevue, WANPI 1992931711

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $782 and has fallen 78.3% since, to $170 in 2025.

$2,892in general payments, 2019–2025

Across 106 payments — averaging $27.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$488
  • AbbVie$462
  • SPR Therapeutics, Inc$326
  • Abbott$205
  • Boston Scientific$175
  • Lilly USA, LLC$154
  • plus $1K from 23 others

What the payments were for

  • Consulting fees$1003%
  • Food & beverage$2,77696%
  • Entertainment$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,892 in reported general payments places this provider in the 55th percentile of 124 pain medicine providers in Washington.

See all pain medicine providers in Washington

Medicare billing

Part B allowed, 2024
$155,377
Medicare patients
200
Services billed
2,418

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine20$3,536
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl16$2,308
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen70$2,087
Oxycodone Hcl89$1,318
Buprenorphine Hcl32$1,229
Pregabalin27$539
Tramadol Hcl23$235
Hydromorphone Hcl17$190
Baclofen16$164
Tizanidine Hcl11$117

Paid to pharmacies, not to this prescriber.

Other pain medicine in Bellevue

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →